{"abstract": "The chief executive of Amgen said Monday that the company\u2019s decision to sell Japanese distribution rights to many of the drugs in its pipeline was not solely a response to financial pressures caused by the decline in sales of Amgen\u2019s flagship anemia drugs.", "web_url": "https://dealbook.nytimes.com/2008/02/05/amgen-sells-drug-rights-and-unit-in-japan/", "snippet": "", "lead_paragraph": "The chief executive of Amgen said Monday that the company\u2019s decision to sell Japanese distribution rights to many of the drugs in its pipeline was not solely a response to financial pressures caused by the decline in sales of Amgen\u2019s flagship anemia drugs.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Amgen Sells Drug Rights and Unit in Japan", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2008-02-05T12:12:13+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/19dd14b8-55b2-5c80-a4d8-1c54acd0725a", "word_count": 306, "uri": "nyt://article/19dd14b8-55b2-5c80-a4d8-1c54acd0725a"}